Associate Director, Global Medical Affairs Training & Development HEOLs

The Role

The Associate Director, HEOL Training – Solid Tumor and Hematology is responsible for developing, implementing, and continuously elevating Genmab’s training curricula supporting the Health Evidence and Outcomes Liaisons (HEOLs) and cross‑functional Medical Affairs partners. This individual collaborates closely with HEOL leadership, Center for Observational Research, Real‑world Evidence and Epidemiology (CORE), Medical Training, Medical Affairs Strategy, Market Access, Field Medical Affairs (FMA), Medical Communications, Commercial Training, and Compliance to ensure training programs—both scientific and functional—meet the evolving needs of the HEOL team working across solid tumor and hematology disease areas.

The HEOL team serves as Genmab’s field‑based Medical Affairs function working to establish access and operational success across payor organizations. HEOLs provide scientific exchange and proactively communicate the clinical and economic value of Genmab’s pipeline pursuant to FDAMA 114 and the 21st Century Cures Act.

• Build and maintain a comprehensive HEOL training framework aligned to scientific, functional, and industry‑standard competencies.
• Ensure the delivery of fair‑balanced, evidence‑based scientific and outcomes‑related information across solid tumor and hematology therapeutic areas.
• Strengthen associates’ capabilities in interpreting clinical, economic, and real‑world data to support scientific exchange with HCPs, payers, and other healthcare stakeholders.
• Foster strategic thinking, innovation, functional excellence, and Health Evidence and Outcomes Research (HEOR)/market access literacy across Medical Affairs.
• Support organizational compliance by partnering with Compliance to ensure all HEOL and Medical Affairs training materials follow relevant policies and procedures.

1. Strategic Training Leadership

• Provide strategic oversight and direction for HEOL‑specific scientific, functional, and competency‑based training aligned with organizational priorities.
• Build and maintain a comprehensive HEOL onboarding program, including a 90‑day learning plan tailored to solid tumor and hematology therapeutic areas.
• Develop comprehensive congress training plan to ensure HEOL training is embedded in congress planning activities for large congresses and available for payor congresses, as needed.
• Support ongoing continuing education, including clinical landscape training, HEOR fundamentals, payer landscape insights, and scientific certification programs.

2. Cross‑Functional Collaboration

• Partner with in‑house CORE, HEOL, FMA, and Medical Affairs Strategy Leadership to assess training needs and ensure scientific and functional content is relevant and up‑to‑date.
• Collaborate with Medical Information and Medical Communications on training for approved scientific materials and evidence dissemination.
• Coordinate with US Market Access, in‑house CORE, and Medical Training colleagues to ensure role‑specific training for HEOLs and Market Access field colleagues.
• Work with Commercial Training as appropriate to align scientific and HEOL‑related content for launch and market‑shaping activities.

3. Program Development & Execution

• Develop and maintain training documentation, curricula, and competency maps for HEOL and related functions.
• Working with in‑house CORE, create and manage a functional annual Training Plan as part of the Medical Planning process, inclusive of launch‑readiness support.
• Lead internal training prior to and following key congresses to highlight new scientific, clinical, or HEOR‑focused data of strategic relevance, inclusive of data on Genmab’s products and key competitive intelligence.
• Develop and deliver CORE and HEOL Training Content in collaboration with cross‑functional partners.
• Manage external training vendors and content providers as needed to ensure high‑quality, compliant programs.

4. Compliance & Operational Excellence

• Partner with Compliance to design and deliver training related to compliance expectations for evidence dissemination, payer engagement, and HEOR‑related communication.
• Review and advise on materials and stakeholder engagement plans…